Joint Declaration

JOINT DECLARATION

We, representatives of civil society – consumer, patient and public health organisations—have formed the European Alliance for Responsible R&D and Affordable Medicines.

In Europe and worldwide, the price of new medicines is rising year on year, especially where there is no therapeutic alternative. As a result, treatment for life-threatening infections and diseases, like HIV/AIDS, cancer and hepatitis C, are increasingly unaffordable for both individuals and national health systems. This is the result of an ineffective and costly research and development (R&D) system that rewards new medicines with fixed-term monopolies (patents) and encourages unaffordable price setting. This patent-based system grants pharmaceutical companies monopolies, which allow them to charge exorbitant prices totally unconnected to the cost of developing and manufacturing the medicines. Urgent measures must be taken to ensure that people can afford the medicines they need. At the same time, new models of R&D must be engaged to meet therapeutic needs.

We call for the creation of an R&D system that is driven by public health needs and delivers medicines that are universally accessible and affordable.

For this to be achieved:

  • New medicines should be safe, effective and offer real therapeutic progress.
  • Relevant data should be in the public domain so it can be independently and transparently assessed.
  • Pharmaceutical R&D must not be driven by monopoly protection, which results in high medicine prices.
  • Pharmaceutical R&D should result in public goods and medicines that are needed and affordable.
  • The pharmaceutical policy process should be fully transparent and developed in consultation with independent stakeholders to avoid conflicts of interest.

We call on policymakers to:

  • Secure affordable prices now. Address urgent access and affordability issues for life-saving medicines by negotiating lower medicine prices and using effective price control mechanisms, including compulsory licences.
  • Put an end to pharmaceutical monopolies. Promote generic and biosimilar competition, including stimulating their uptake by healthcare programmes, doctors and patients, and increase scrutiny of anti-competitive practices by the pharmaceutical industry.
  • Implement full transparency of pharmaceutical R&D, as well as medicine price setting, by:
    • Promoting open access to research data, including data from early stage research and all clinical trials, for both existing and new medicines;
    • Fully disclosing and tracking public and private funding for pharmaceutical R&D;
    • Establishing a publicly accessible database where national or regional health systems publish the actual price of medicines that they negotiate, including discounts and rebates.
  • Promote a new biomedical R&D model by:
    • Committing increased public funds to support a needs-driven approach to pharmaceutical R&D that does not rely on monopoly protection and high prices. New R&D models which delink the incentive to develop medicines from the expectation of high prices could include innovation inducement prizes, patent pools, open source research, product development partnerships and publicly led and funded R&D;
    • Introducing conditions to public R&D funding that ensure biomedical research results in suitable and affordable medicines (e.g., non-exclusive licensing policies, open access publishing and data sharing and health-needs-driven priority setting).

The European Alliance for Responsible R&D and Affordable Medicines is comprised of the following consumer, patient and public health organisations:

  1. Access to Medicines Ireland – accesstomedicines.ie
  2. AIDES– aides.org
  3. Aids Action Europe– aidsactioneurope.org
  4. Aidsfondshttps://aidsfonds.org/
  5. Aktionsbündnis gegen AIDS– aids-kampagne.de
  6. Altroconsumo– altroconsumo.it
  7. Asociación por un Acceso Justo al Medicamentohttps://www.accesojustomedicamento.es/
  8. Barcelona Institute for Global Health (ISGLOBAL)https://www.isglobal.org/en/
  9. BEUC – The European Consumer Organisation– beuc.eu
  10. Buko Pharma-Kampagne –bukopharma.de
  11. Civio Foundationhttps://civio.es/en/
  12. CO 100 PERCENT LIFE– network.org.ua
  13. Commons Network– commonsnetwork.eu
  14. Dying for a Cure – dyingforacure.org
  15. EKPIZO– ekpizo.gr
  16. European AIDS Treatment Group – EATG– eatg.org
  17. European Public Health Alliance – EPHA– epha.org
  18. Forbrugerrådet Tænk– taenk.dk
  19. France Assos Santéfrance-assos-sante.org
  20. GAT Portugal– gatportugal.org
  21. Global Health Advocates – GHA– ghadvocates.org
  22. Global Justice Nowglobaljustice.org.uk
  23. Groupe sida Genèvegroupesida.ch
  24. Health Action International – HAI – haiweb.org
  25. Health and Trade Network– healthandtradenetwork.org
  26. Health Projects for Latvia– veselibasprojekti.lv
  27. Hepatitis Scotland – hepatitisscotland.org.uk
  28. International Society of Drug Bulletins– isdbweb.org
  29. Just Treatmentjusttreatment.org
  30. Knowledge Ecology International – KEI– keionline.org
  31. Medecins du Monde/Doctors of the world– medecinsdumonde.org
  32. Médecins Sans Frontières (MSF) Access Campaign– msfaccess.org
  33. Medicines Law and Policy medicineslawandpolicy.org
  34. MEZIS e.V. – Mein Essen zahl ich selbst– mezis.de
  35. Mundo Sano– mundosano.org
  36. No Es Sanonoessano.org
  37. NoGracias – nogracias.eu
  38. Organizacion de Consumidores y Usuarios – OCU– ocu.org
  39. Oxfamoxfam.org
  40. Plataforma de afectados por hepatitis C – PLAFHC – plataformadeafectadosporhepatitisc.org/
  41. PRAKSIS– praksis.gr
  42. Prescrire – org
  43. Public Eye – publiceye.ch
  44. Salud por Derecho– saludporderecho.org
  45. STOPAIDS– stopaids.org.uk
  46. T1 Internationalt1international.com
  47. Test Aankoop – Test Achats– test-aankoop.bewww.test-achats.be
  48. Transparency International Pharmaceuticals & Healthcare Programme – transparency.org.uk
  49. TranspariMEDtransparimed.org
  50. UAEM – Universities Allied for Essential Medicines– uaem.org
  51. Verein demokratischer Pharmazeutinnen und Pharmazeuten – VdPP– vdpp.de
  52. Wemos– wemos.nl
  53. Youth Stop AIDSyouthstopaids.org